138 related articles for article (PubMed ID: 15004586)
1. Conjunctival pigmentation as an adverse effect of latanoprost.
Moosavi AH; Sarhan MM; Niyadurupola T
Eye (Lond); 2004 Mar; 18(3):319-20. PubMed ID: 15004586
[No Abstract] [Full Text] [Related]
2. A correlation between latanoprost-induced conjunctival hyperemia and intraocular pressure-lowering effect.
Kobayashi H; Kobayashi K
J Glaucoma; 2011 Jan; 20(1):3-6. PubMed ID: 20520573
[TBL] [Abstract][Full Text] [Related]
3. The clinical impact and incidence of periocular pigmentation associated with either latanoprost or bimatoprost therapy.
Sharpe ED; Reynolds AC; Skuta GL; Jenkins JN; Stewart WC
Curr Eye Res; 2007 Dec; 32(12):1037-43. PubMed ID: 18085467
[TBL] [Abstract][Full Text] [Related]
4. Latanoprost-induced Skin Depigmentation.
Lin M; Schmutz M; Mosaed S
J Glaucoma; 2017 Nov; 26(11):e246-e248. PubMed ID: 29099736
[TBL] [Abstract][Full Text] [Related]
5. Increased eyelid pigmentation associated with use of latanoprost.
Kook MS; Lee K
Am J Ophthalmol; 2000 Jun; 129(6):804-6. PubMed ID: 10926995
[TBL] [Abstract][Full Text] [Related]
6. Topical prostaglandin F(2alpha) analog induced poliosis.
Chen CS; Wells J; Craig JE
Am J Ophthalmol; 2004 May; 137(5):965-6. PubMed ID: 15126178
[TBL] [Abstract][Full Text] [Related]
7. Latanoprost and pigmentation.
Grierson I; Jonsson M; Cracknell K
Jpn J Ophthalmol; 2004; 48(6):602-12. PubMed ID: 15592791
[TBL] [Abstract][Full Text] [Related]
8. Morphometric effects of long-term exposure to latanoprost.
Cracknell KP; Grierson I; Hogg P
Ophthalmology; 2007 May; 114(5):938-48. PubMed ID: 17292473
[TBL] [Abstract][Full Text] [Related]
9. Choroidal detachment with topical latanoprost after glaucoma filtration surgery.
Sodhi PK; Sachdev MS; Gupta A; Verma LK; Ratan SK
Ann Pharmacother; 2004 Mar; 38(3):510-1. PubMed ID: 14970375
[No Abstract] [Full Text] [Related]
10. Effect of latanoprost 0.005% and brimonidine 0.2% on intraocular pressure after phacoemulsification and intraocular lens implantation surgery.
Erdogan H; Toker MI; Arici MK; Topalkara A
Jpn J Ophthalmol; 2004; 48(6):600-1. PubMed ID: 15592790
[No Abstract] [Full Text] [Related]
11. Iris morphology.
Teus MA; Arranz-Marquez E
Ophthalmology; 2008 Feb; 115(2):418-9; author reply 419-20. PubMed ID: 18243921
[No Abstract] [Full Text] [Related]
12. Poliosis associated with treatment of fungal endophthalmitis.
Watson AS; Giledi O; Daya SM
Orbit; 2004 Dec; 23(4):241-4. PubMed ID: 15590526
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of iridial pigmentation and eyelash changes due to ophthalmic treatment with latanoprost.
Chiba T; Kashiwagi K; Ishijima K; Furuichi M; Kogure S; Abe K; Chiba N; Tsukahara S
Jpn J Ophthalmol; 2004; 48(2):141-7. PubMed ID: 15060793
[TBL] [Abstract][Full Text] [Related]
14. Assessment of chamber angle pigmentation during longterm latanoprost treatment for open-angle glaucoma.
Nakamura Y; Nakamura Y; Morine-Shinjo S; Sakai H; Sawaguchi S
Acta Ophthalmol Scand; 2004 Apr; 82(2):158-60. PubMed ID: 15043533
[TBL] [Abstract][Full Text] [Related]
15. Increased iris pigment in a child due to latanoprost.
Brown SM
Arch Ophthalmol; 1998 Dec; 116(12):1683-4. PubMed ID: 9869807
[No Abstract] [Full Text] [Related]
16. Evidence of early change in iris color with latanoprost use.
Pappas RM; Pusin S; Higginbotham EJ
Arch Ophthalmol; 1998 Aug; 116(8):1115-6. PubMed ID: 9715697
[No Abstract] [Full Text] [Related]
17. Side effects associated with prostaglandin analog therapy.
Alm A; Grierson I; Shields MB
Surv Ophthalmol; 2008 Nov; 53 Suppl1():S93-105. PubMed ID: 19038628
[TBL] [Abstract][Full Text] [Related]
18. Lash ptosis caused by latanoprost.
Casson RJ; Selva D
Am J Ophthalmol; 2005 May; 139(5):932-3. PubMed ID: 15860312
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the additive effect of bunazosin on latanoprost in primary open-angle glaucoma.
Maruyama K; Shirato S; Haneda M
Jpn J Ophthalmol; 2005; 49(1):61-2. PubMed ID: 15692779
[No Abstract] [Full Text] [Related]
20. Severe darkening of a facial skin graft from latanoprost.
Calladine D; Harrison RJ
Arch Ophthalmol; 2007 Oct; 125(10):1427-8. PubMed ID: 17923558
[No Abstract] [Full Text] [Related]
[Next] [New Search]
